Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin/Metformin) are Type-2 diabetes drugs intended to help control blood sugar levels. A recent clinical trial, however, concluded that users of Onglyza and Kombiglyze XR are more likely to suffer from heart failure. Onglyza users have filed lawsuits alleging AstraZeneca, the manufacturer of Onglyza and Kombiglyze XR, failed to warn users of the increased risk of heart failure. People who have suffered from heart failure while taken Onglyza or Kombiglyze XR may be entitled to substantial compensation for their injuries.

Meshbesher & Spence is currently providing free and confidential consultations for people who were diagnosed with heart failure while using Onglyza or Kombiglyze. To learn more about your legal rights, or the legal rights of a loved one, contact us today for a free and confidential consultation by calling 1-888-728-9866 or by sending an email to

You need to know that a person injured by a dangerous drug has a limited amount of time to file a lawsuit. Contact us today to discuss the applicable time limits for your potential case.

Clinical Trials Find Onglyza and Kombiglyze XR Increase the Risk of Heart Failure

A recent clinical trial evaluated 16,492 Type-2 diabetics to determine the safety and efficacy of Onglyza. The trial is known as the SAVOR Study. The SAVOR study found that people taking Onglyza were 27% more likely to require hospitalization for heart failure compared to people who did not take Onglyza. Dr. Benjamin Scirica, the SAVOR Principle Investigator, said this about alarming results:

“Though unexpected, the incremental risk of heart failure hospitalizations observed with saxagliptin is likely valid…”

In addition to the increased risk of heart failure, Onglyza’s efficacy has also recently come into question. Express Scripts, the largest U.S. pharmacy benefit manager, recently decided to exclude Onglyza and Kombiglyze XR from insurance coverage because the drugs cost more than comparable products, but have shown no additional benefit beyond other drugs that are more affordable.

FDA Advisory Committee

Following the release of the SAVOR study, the FDA formed an Advisory Committee of 15 members to evaluate Onglyza. At the conclusion of the meeting, 14 of the members recommended Onglyza and Kombiglyze XR should have a label that warns users of heart failure. The remaining Committee member recommended AstraZeneca should stop selling Onglyza and Kombiglyze XR. To date, the labels of Onglyza and Kombiglyze XR still do not warn people of the increased risk of heart failure.

Onglyza and Kombiglyze XR Lawsuits

People from across the country have filed lawsuits alleging AstraZeneca failed to warn users that Onglyza and Kombiglyze XR failed to warn users of the increase risk of heart failure. The Onglyza lawsuits are not part of a class action. Meshbesher & Spence is filing individual lawsuits because we recognize each situation is unique and deserves specialized attention. If you were diagnosed with heart failure, congestive heart failure or cardiac failure while taking Onglyza or Kombiglyze XR, you may be eligible to file a lawsuit to recover the following damages:

Pain and Suffering
Past and Future Medical Expenses
Past and Future Lost Wages
If you lost a loved one who died of heart failure while taking Onglyza or Kombiglyze XR, you may be eligible to pursue a wrongful death lawsuit on behalf of the heirs.

The Lawyer You Choose Makes a Difference

Meshbesher & Spence has represented thousands of individuals who were injured by dangerous drugs and faulty medical systems. Meshbesher & Spence has led the charge in some of the most high-profiled litigations involving the largest pharmaceutical drug and medical device manufacturers. If you have been injured while taking Onglyza or Kombiglyze, you need a law firm with a proven record that is willing to give your case the individual attention it deserves. The lawyer you choose makes a difference.

If you or a loved one suffered heart failure while taking Onglyza or Kombiglyze XR, call us today at 1-888-728-9866 or email us at for a free and private consultation to discuss your legal rights. Attorneys at Meshbesher & Spence are standing by to answer your question and to discuss your options.

Remember, a person has a limited time to file a lawsuit after being injured by a pharmaceutical drug. Failure to file a lawsuit within the applicable time might prevent you from seeking recovery for your injuries. If you or a loved one suffered heart failure while taking Onglyza or Kombiglyze XR, contact us today at 1-888-728-9866 or at